Search research articles
Contact Us
Filters
Showing results (111-120 of 132) with videos related to
Page
of 14
Sort By:
Journal of Medicinal Chemistry
|
April 28, 2018
Fluorine-Substituted Pyrrolo[2,3- d]Pyrimidine Analogues with Tumor Targeting via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis
Manasa Ravindra, Mike R Wilson, Nian Tong, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 28, 2015
A small molecule with anticancer and antimetastatic activities induces rapid mitochondrial-associated necrosis in breast cancer
Anja Bastian, Jessica E Thorpe, Bryan C Disch, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 9, 2026
Discovery of multitargeting single agents as a novel route to the potential treatment of neurodegenerative diseases
Jeetal Vyas, Anuj S Jamenis, Krishna Kaku, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 15, 2025
Pharmacodynamic determinants of mitochondrial one-carbon flux and serine hydroxymethyltransferase inhibition in human tumors
Mathew Schneider, Carrie O'Connor, Xun Bao, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 2, 2012
Intestinal transport of aminopterin enantiomers in dogs and humans with psoriasis is stereoselective: evidence for a mechanism involving the proton-coupled folate transporter
Alan Menter, Breck Thrash, Christina Cherian, et al.
Journal of Medicinal Chemistry
|
February 10, 2018
Tumor Targeting with Novel Pyridyl 6-Substituted Pyrrolo[2,3- d]Pyrimidine Antifolates via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of De Novo Purine Nucleotide Biosynthesis
Manasa Ravindra, Adrianne Wallace-Povirk, Mohammad A Karim, et al.
Molecular Pharmacology
|
November 11, 2019
Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-<i>d</i>]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism
Aamod S Dekhne, Changwen Ning, Md Junayed Nayeen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
March 25, 2026
Determination of the pyrrolo[2,3-d] pyrimidine antifolate AGF94 from a preclinical murine study using a simple UHPLC-MS/MS assay
Tryston T Metz, Rachel C Ashe, Alexis C Duncan, et al.
Molecular Cancer Therapeutics
|
February 1, 2017
Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-<i>d</i>]pyrimidine Antifolates
Zhanjun Hou, Leda Gattoc, Carrie O'Connor, et al.
Bioorganic & Medicinal Chemistry
|
March 27, 2021
Discovery of 6-substituted thieno[2,3-d]pyrimidine analogs as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis in folate receptor expressing human tumors
Adrianne Wallace-Povirk, Nian Tong, Jennifer Wong-Roushar, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 132) with videos related to
Sort By:
Page
of 14
Journal of Medicinal Chemistry
|
April 28, 2018
Fluorine-Substituted Pyrrolo[2,3- d]Pyrimidine Analogues with Tumor Targeting via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis
Manasa Ravindra, Mike R Wilson, Nian Tong, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 28, 2015
A small molecule with anticancer and antimetastatic activities induces rapid mitochondrial-associated necrosis in breast cancer
Anja Bastian, Jessica E Thorpe, Bryan C Disch, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 9, 2026
Discovery of multitargeting single agents as a novel route to the potential treatment of neurodegenerative diseases
Jeetal Vyas, Anuj S Jamenis, Krishna Kaku, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 15, 2025
Pharmacodynamic determinants of mitochondrial one-carbon flux and serine hydroxymethyltransferase inhibition in human tumors
Mathew Schneider, Carrie O'Connor, Xun Bao, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 2, 2012
Intestinal transport of aminopterin enantiomers in dogs and humans with psoriasis is stereoselective: evidence for a mechanism involving the proton-coupled folate transporter
Alan Menter, Breck Thrash, Christina Cherian, et al.
Journal of Medicinal Chemistry
|
February 10, 2018
Tumor Targeting with Novel Pyridyl 6-Substituted Pyrrolo[2,3- d]Pyrimidine Antifolates via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of De Novo Purine Nucleotide Biosynthesis
Manasa Ravindra, Adrianne Wallace-Povirk, Mohammad A Karim, et al.
Molecular Pharmacology
|
November 11, 2019
Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-<i>d</i>]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism
Aamod S Dekhne, Changwen Ning, Md Junayed Nayeen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
March 25, 2026
Determination of the pyrrolo[2,3-d] pyrimidine antifolate AGF94 from a preclinical murine study using a simple UHPLC-MS/MS assay
Tryston T Metz, Rachel C Ashe, Alexis C Duncan, et al.
Molecular Cancer Therapeutics
|
February 1, 2017
Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-<i>d</i>]pyrimidine Antifolates
Zhanjun Hou, Leda Gattoc, Carrie O'Connor, et al.
Bioorganic & Medicinal Chemistry
|
March 27, 2021
Discovery of 6-substituted thieno[2,3-d]pyrimidine analogs as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis in folate receptor expressing human tumors
Adrianne Wallace-Povirk, Nian Tong, Jennifer Wong-Roushar, et al.
Page
of 14